Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)
www.advfn.com/news_Prospectus-Filed-Pursuant-to-Rule-424b5...
11 hours ago - We plan to expand our Imprimis Cares program by introducing additional customizable compounded drug formulations for patient populations that may not have
ADVFN
No comments:
Post a Comment